J Res Med Sci. 2013 Dec;18(12):1046-50.

Absent CD56 expression in papillary thyroid carcinoma: A finding of potential diagnostic value in problematic cases of thyroid pathology.

Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences

Mozhgan Mokhtari, Mehdi Eftekhari, Reza Tahririan

PMID: 24523794 PMCID: PMC3908524

Abstract

BACKGROUND: There are inter-observer disagreements between papillary thyroid carcinoma (PTC) with other follicular lesions of thyroid in aspect of diagnosis. CD56 is present on follicular epithelial cells of the normal thyroid. We evaluated the diagnostic value of CD56 expression in PTC, follicular thyroid lesions, and follicular thyroid neoplasms.

MATERIALS AND METHODS: Seventy-three cases diagnosed as follicular lesions and 73 cases diagnosed as PTC were stained with CD56 marker. A positive membranous immunostaining in more than 10% of the neoplastic cells qualified the case as "positive (+)" for CD56.

RESULTS: CD56 expression was seen in 70 samples of non-papillary carcinoma lesion (95.8%) versus one case of PTC (1.3%) (P < 0.001, Chi-square). Therefore, CD56 was 98.6% sensitive and 95.8% specific in distinguishing PTC from other follicular thyroid lesions.

CONCLUSION: CD56 is both a sensitive and specific marker for differentiating PTC from other follicular lesions of thyroid singly but it may be better to use a combination of markers for clinical evaluation of patients.

Keywords: CD56; papillary thyroid carcinoma; thyroid neoplasms; thyroid nodule

References

1. Endocr Pathol. 2008 Summer;19(2):92-6 - PubMed
2. J Exp Med. 1989 Jun 1;169(6):2233-8 - PubMed
3. Folia Histochem Cytobiol. 1999;37(1):11-7 - PubMed
4. Mod Pathol. 2001 Apr;14(4):338-42 - PubMed
5. Adv Anat Pathol. 2004 Nov;11(6):279-87 - PubMed
6. Clin Exp Immunol. 1992 Sep;89(3):474-8 - PubMed
7. J Clin Endocrinol Metab. 2004 Jul;89(7):3214-23 - PubMed
8. Am J Surg Pathol. 2004 Oct;28(10):1336-40 - PubMed
9. Mod Pathol. 2005 Jan;18(1):48-57 - PubMed
10. Langenbecks Arch Surg. 2010 Sep;395(7):885-91 - PubMed
11. J Pathol. 2007 Aug;212(4):411-9 - PubMed
12. Clin Endocrinol (Oxf). 2004 Jan;60(1):18-20 - PubMed
13. Hum Pathol. 2012 Aug;43(8):1221-8 - PubMed
14. Endocr Pract. 2004 May-Jun;10(3):234-41 - PubMed
15. Histopathology. 2005 Oct;47(4):391-401 - PubMed
16. Surgery. 2001 Nov;130(5):834-43 - PubMed
17. Folia Histochem Cytobiol. 1998;36(3):119-25 - PubMed
18. Virchows Arch. 2006 Apr;448(4):385-93 - PubMed
19. Science. 1988 Apr 1;240(4848):53-7 - PubMed
20. Int J Immunopathol Pharmacol. 1999 Jan-Apr;12(1):23-30 - PubMed
21. Acta Pathol Microbiol Scand A. 1978 Nov;86A(6):483-6 - PubMed
22. Diagn Pathol. 2008 Feb 06;3:5 - PubMed
23. Am J Pathol. 2002 Jan;160(1):175-83 - PubMed
24. Nat Cell Biol. 2001 Jul;3(7):650-7 - PubMed
25. J Egypt Natl Canc Inst. 2012 Dec;24(4):175-84 - PubMed
26. APMIS. 2011 Aug;119(8):529-36 - PubMed
27. Endocr Pathol. 2006 Spring;17(1):1-18 - PubMed
28. Surgery. 1999 Dec;126(6):1056-61; discussion 1061-2 - PubMed
29. Pathol Res Pract. 2009;205(5):303-9 - PubMed
30. Am J Clin Pathol. 2002 Jan;117(1):16-8 - PubMed
31. Cancer. 1998 Dec 15;83(12):2638-48 - PubMed
32. Anticancer Res. 1997 Mar-Apr;17(2B):1227-30 - PubMed
33. Endocrinol Metab Clin North Am. 2007 Sep;36(3):707-35, vi - PubMed

Publication Types

• Journal Article